Syndax Pharmaceuticals SNDX Stock
Syndax Pharmaceuticals Price Chart
Syndax Pharmaceuticals SNDX Financial and Trading Overview
| Syndax Pharmaceuticals stock price | 13.38 USD |
| Previous Close | 21.82 USD |
| Open | 21.69 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 21.17 - 21.74 USD |
| 52 Week Range | 15.76 - 29.86 USD |
| Volume | 830.39K USD |
| Avg. Volume | 941.92K USD |
| Market Cap | 1.47B USD |
| Beta (5Y Monthly) | 1.129577 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.72 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34 USD |
SNDX Valuation Measures
| Enterprise Value | 1.06B USD |
| Trailing P/E | N/A |
| Forward P/E | -7.0863786 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.3548286 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.617 |
Trading Information
Syndax Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.129577 |
| 52-Week Change | 26.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 29.86 USD |
| 52 Week Low | 15.76 USD |
| 50-Day Moving Average | 20.77 USD |
| 200-Day Moving Average | 23.18 USD |
SNDX Share Statistics
| Avg. Volume (3 month) | 941.92K USD |
| Avg. Daily Volume (10-Days) | 929.76K USD |
| Shares Outstanding | 68.82M |
| Float | 58.34M |
| Short Ratio | 6.69 |
| % Held by Insiders | 4.18% |
| % Held by Institutions | 106.98% |
| Shares Short | 6.22M |
| Short % of Float | 11.82% |
| Short % of Shares Outstanding | 9.03% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.80% |
| Return on Equity (ttm) | -37.84% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -160888992 USD |
| Net Income Avi to Common (ttm) | -153295008 USD |
| Diluted EPS (ttm) | -2.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 438.2M USD |
| Total Cash Per Share (mrq) | 6.37 USD |
| Total Debt (mrq) | 1.06M USD |
| Total Debt/Equity (mrq) | 0.24 USD |
| Current Ratio (mrq) | 18.613 |
| Book Value Per Share (mrq) | 6.358 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -130972000 USD |
| Levered Free Cash Flow (ttm) | -80895000 USD |
Profile of Syndax Pharmaceuticals
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 35 Gatehouse Drive |
| ZIP | 02451 |
| Phone | 781 419 1400 |
| Website | https://www.syndax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 107 |
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 for the treatment of KMT2A rearranged (KMT2Ar) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
Q&A For Syndax Pharmaceuticals Stock
What is a current SNDX stock price?
Syndax Pharmaceuticals SNDX stock price today per share is 13.38 USD.
How to purchase Syndax Pharmaceuticals stock?
You can buy SNDX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Syndax Pharmaceuticals?
The stock symbol or ticker of Syndax Pharmaceuticals is SNDX.
Which industry does the Syndax Pharmaceuticals company belong to?
The Syndax Pharmaceuticals industry is Biotechnology.
How many shares does Syndax Pharmaceuticals have in circulation?
The max supply of Syndax Pharmaceuticals shares is 86.04M.
What is Syndax Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Syndax Pharmaceuticals PE Ratio is now.
What was Syndax Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Syndax Pharmaceuticals EPS is -3.72 USD over the trailing 12 months.
Which sector does the Syndax Pharmaceuticals company belong to?
The Syndax Pharmaceuticals sector is Healthcare.
Syndax Pharmaceuticals SNDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17152.22 USD — |
-1.33
|
6.66B USD — | 17128.71 USD — | 17467.35 USD — | — - | 6.66B USD — |
| NASDAQ Global Select Market Com NQGS | 8390.08 USD — |
-1.34
|
— — | 8380.89 USD — | 8543.96 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4158.72 USD — |
+0.66
|
— — | 4155.12 USD — | 4202.15 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 924.57 USD — |
+0.11
|
— — | 923.44 USD — | 934.48 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2054.99 USD — |
-0.49
|
— — | 2054.51 USD — | 2085.49 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4157.43 USD — |
+0.21
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
- {{ link.label }} {{link}}